BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT02694523 · COMPLETED
Trial details
- NCT number
- NCT02694523
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-08-01
- Enrollment
- 684
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.